- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01875419
Non-invasive Brain Stimulation and Cognitive Processing in Depression
Neural, Cognitive, and Clinical Effects of Prefrontal Cortex Stimulation to Enhance Psychotherapy in Depression: a Double-blind Randomized Controlled Trial
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
We propose to investigate the effect of applying transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex (LDLPFC) immediately prior to each of 8 sessions of cognitive behavioural therapy (CBT), a type of psychological therapy. In addition we will investigate whether tDCS effects on CBT are due to changes in cognitive control using both behavioural and neuroimaging measures.
We hypothesize that tDCS, thanks to its enduring effects, should improve the benefits of CBT, through the enhancement of cognitive control in the patient.
Null hypothesis: mood and cognitive performance will be equivalent in depressed individuals who undergo tDCS and those who undergo sham stimulation.
Experimental hypothesis: mood and cognitive performance will be improved in depressed individuals who undergo tDCS relative to those who undergo sham stimulation.
Sixty patients suffering from depression will be recruited, and a double-blind, sham-controlled, randomised design will be used. This design means that neither participants nor researchers are aware of the conditions they have been assigned to, and has been chosen to eliminate participant expectancy ("placebo") effects and researcher bias. To ensure that 30 participants are included in each group, we will use a balanced assignment algorithm at entry into the study, which will maximise statistical power. Since the results of a study of this type have never previously been reported (to our knowledge), clinical equipoise exists, mandating the use of a sham stimulation arm. Patients with depression will be randomly assigned to one of two groups: tDCS or sham stimulation. To ensure that 30 participants are included in each group, we will use a balanced assignment algorithm at entry into the study. The whole study will be spread over 16 weeks for each participant with the following time course:
- start: baseline MRI brain scan while completing a cognitive control task; measures of depressive symptoms
- weeks 1 to 8: one session per week of tDCS or sham stimulation (20 min, while completing a cognitive control task) immediately followed by CBT (1 hour); measures of depressive symptoms
- end of week 8: post-treatment MRI scan while completing a cognitive control task and measures of depressive symptoms
- week 9 to 16: up to one session per week of CBT as usual (1 hour) without stimulation
- end of week 16, or end of CBT (whichever is sooner): measures of depressive symptoms
MRI scans will have two purposes, (1) localising the area of the DLPFC for stimulation, and (2) comparing brain responses to a cognitive control task before and after treatment.
The tDCS will be delivered using neuroConn stimulators. A 1 milliamp (mA) current will be delivered for 20 minutes through damp sponges soaked in saline solution and attached to the head of the patient using a cap. One electrode will be placed on the forehead over the LDLPFC, and the other on the left shoulder blade or left cheek to record baseline electrical signal. In the sham condition, there will be a brief current change at the beginning and end of each stimulation session, in order to mimic the effect of an actual stimulation, but no current will be delivered in between.
CBT sessions will be delivered weekly, immediately after the tDCS or sham stimulation for the first 8 weeks, and provided by qualified psychological therapists as part of standard National Health Services (NHS) care.
Mood will be assessed before the start of the study (first MRI scan), each week for the 8 week stimulation phase, at the second MRI scan and after 16 weeks, using the Montgomery and Asberg Depression Rating Scale (MADRS).
Patients will perform a task to assess their cognitive control abilities during the MRI scans, as well as during each of the 8 stimulation sessions. During this task, visual stimuli will be presented to the subject, who will have to make different responses to these stimuli by pressing buttons on a response box.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
London, Reino Unido, WC1N 3AR
- UCL Institute of Cognitive Neuroscience
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Patients suffering from unipolar major depressive disorder
- First depressive episode onset before 40 years old
- Right-handedness
- English as first language
- Intention to commence a course of cognitive behavioural therapy
Exclusion Criteria:
- Antidepressant or other psychotropic medication at any time during the study or within previous 4 weeks (8 for fluoxetine)
- Recent illicit drug use
- Prior mixed, manic, or psychotic symptoms or other psychiatric or neurological illness
- Standard exclusion criteria for MRI scanning: pregnancy, breast feeding, any immovable metal in the body, weight above 250 lbs, claustrophobia
- tDCS safety criteria: skin disease or skin treatment that could potentially cause irritation with electrical stimulation
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Patients tDCS
A group of 30 patients will receive active tDCS stimulation once a week for 8 weeks, immediately prior to CBT.
|
Patients - tDCS arm: 1 mA current delivered for 20 minutes once a week for 8 weeks, immediately prior to CBT. Patients - Sham arm: brief current change at the beginning (0 min) and end of each stimulation session (20 min) in order to mimic the effect of an actual stimulation, but no current delivered in between.
Otros nombres:
8 sessions of one hour (once weekly) immediately after tDCS or sham stimulation
|
Comparador falso: Patients - Sham
Another group of 30 patients will receive sham stimulation once a week during 8 weeks, immediately prior to CBT.
|
8 sessions of one hour (once weekly) immediately after tDCS or sham stimulation
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Beck Depression Inventory (BDI) score
Periodo de tiempo: Change from Baseline BDI score at 8 sessions
|
BDI scores will constitute a self-report measure of depression symptoms over the course of the trial.
|
Change from Baseline BDI score at 8 sessions
|
Beck Depression Inventory (BDI) score
Periodo de tiempo: Change from Baseline BDI score at 16 sessions or when the patient ceases CBT, whichever came first
|
BDI scores will constitute a self-report measure of depression.
|
Change from Baseline BDI score at 16 sessions or when the patient ceases CBT, whichever came first
|
Hamilton Depression Rating Scale (HAMD)
Periodo de tiempo: Change from Baseline HAMD at 8 CBT sessions
|
HAMD scores will constitute an interview scale from baseline to end of tDCS.
|
Change from Baseline HAMD at 8 CBT sessions
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Cognitive Control Performance
Periodo de tiempo: Week 0 (Baseline), 1, 2, 3, 4, 5, 6, 7, 8, and 9
|
Evolution of behavioral performance on the cognitive control task over the course of the trial, performed inside the scanner at baseline and after session 8, and during tDCS stimulation once a week for 8 weeks.
|
Week 0 (Baseline), 1, 2, 3, 4, 5, 6, 7, 8, and 9
|
Functional Magnetic Resonance Imaging (fMRI) data
Periodo de tiempo: Change from Baseline brain responses to the cognitive control task at week 9
|
Brain responses to the cognitive control task in the LDLPFC and other relevant brain region will be analysed and compared after relative to before treatment.
|
Change from Baseline brain responses to the cognitive control task at week 9
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Stephen Pilling, PhD, University College, London
- Investigador principal: Jonathan P Roiser, PhD, University College, London
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 13/0256
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Transcranial direct current stimulation (tDCS)
-
Minneapolis Veterans Affairs Medical CenterCenter for Veterans Research and EducationTerminadoObesidad | Impulsividad | Comer en exceso compulsivamenteEstados Unidos
-
University of ArkansasReclutamientoAfasiaEstados Unidos
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)TerminadoAnhedonia | Trastorno depresivo mayorEstados Unidos
-
Kaohsiung Medical University Chung-Ho Memorial...Terminado